Avanafil NEW

Avanafil is a highly selective oral phosphodiesteras 5 inhibitor. Phase I, II, and III clinical trials have shown that compared with other phosphodiesteras 5 inhibitors, avanafil has the characteristics of rapid onset, short duration of action, fewer adverse reactions, and good clinical efficacy and safety in the treatment of ed.

Purchase process:

1. Contact the sales department to confirm the product name, quantity, price, packaging, etc.

2. After confirmation, remit the money to our company account and send detailed delivery information

3. Ship within 2 working days after payment and offer tracking number.

4. Customer confirms receipt

Rock

Whatsapp:+8618829283179

Email: rock@horlden.com